WeChat· 药通社·· 4 hours agoPickScore66
METiS Pharmaceuticals and Eli Lilly Strike AI-Driven LNP Delivery Deal with Over $10 Million Upfront
In brief
METiS Pharmaceuticals has entered a collaboration with Eli Lilly on AI-driven LNP delivery technology. Using its AiLNP platform, METiS will develop next-generation delivery technology that improves LNP targeting and in vivo distribution. It will receive an upfront payment of over ten million dollars and is eligible for up to $1.1 billion in development, regulatory and commercial milestone payments.
Why it matters
The disclosed upfront of over ten million dollars and milestones of up to $1.1 billion provide a quantifiable anchor for comparing AI drug-delivery deal sizes and structures.
Source: WeChat · mp.weixin.qq.com